Left ventricular assist device in cardiac amyloidosis: friend or foe?

Garcia-Pavia P, Rapezzi C, Adler Y et al (2021) Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J 42(16):1554–1568

Article  PubMed  PubMed Central  Google Scholar 

Adam RD, Coriu D, Jercan A et al (2021) Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature. ESC Heart Fail 8(4):2380–2396

Article  PubMed  PubMed Central  Google Scholar 

Mohammed SF, Mirzoyev SA, Edwards WD et al (2014) Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail 2:113–122

Article  PubMed  PubMed Central  Google Scholar 

Falk RH (2005) Diagnosis and management of the cardiac amyloidoses. Circulation 112(13):2047–2060

Article  PubMed  Google Scholar 

Di Nora C, Livi U (2020) Heart transplantation in cardiac storage diseases: data on Fabry disease and cardiac amyloidosis. Curr Opin Organ Transplant 25(3):211–217

Article  PubMed  Google Scholar 

Topilsky Y, Pereira NL, Shah DK, Boilson B, Schirger JA, Kushwaha SS et al (2011) Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy. Circ Heart Fail 4(3):266–275

Article  PubMed  Google Scholar 

Molina EJ, Shah P, Kiernan MS et al (2021) The society of thoracic surgeons intermacs 2020 annual report. Ann Thorac Surg 111(3):778–792

Article  PubMed  Google Scholar 

Gustafsson F, Rogers JG (2017) Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes. Eur J Heart Fail 19(5):595–602

Article  PubMed  Google Scholar 

Fukamachi K, Shiose A, Massiello A et al (2013) Preload sensitivity in cardiac assist devices. Ann Thorac Surg 95(1):373–380

Article  PubMed  Google Scholar 

Grupper A, Park SJ, Pereira NL et al (2015) Role of ventricular assist therapy for patients with heart failure and restrictive physiology: improving outcomes for a lethal disease. J Heart Lung Transplant 34(8):1042–1049

Article  PubMed  Google Scholar 

Pagani FD, Miller LW, Russell SD et al (2009) Extended mechanical circulatory support with a continuous-flowrotary left ventricular assist device. J Am Coll Cardiol 54:312–321

Article  PubMed  Google Scholar 

Bellavia D, Iacovoni A, Scardulla C et al (2017) Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies. Eur J Heart Fail 19(7):926–946

Article  CAS  PubMed  Google Scholar 

Bodez D, Ternacle J, Guellich A et al (2016) Prognostic value of right ventricular systolic function in cardiac amyloidosis. Amyloid 23(3):158–167

Article  CAS  PubMed  Google Scholar 

Arvidsson S, Henein MY, Wikström G, Suhr OB, Lindqvist P (2018) Right ventricular involvement in transthyretin amyloidosis. Amyloid 25(3):160–166

Article  CAS  PubMed  Google Scholar 

Patel SR, Saeed O, Naftel D et al (2017) Outcomes of restrictive and hypertrophic cardiomyopathies after LVAD: an INTERMACS analysis. J Card Fail 23(12):859–867

Article  PubMed  Google Scholar 

Imamura T, Kinugawa K, Kato N et al (2014) Late-onset right ventricular failure in patients with preoperative small left ventricle after implantation of continuous flow left ventricular assist device. Circ J 78(3):625–633

Article  CAS  PubMed  Google Scholar 

Vivo RP, Cordero-Reyes AM, Qamar U et al (2013) Increased right-to-left ventricle diameter ratio is a strong predictor of right ventricular failure after left ventricular assist device. J Heart Lung Transplant 32(8):792–799

Article  PubMed  Google Scholar 

Topilsky Y, Oh JK, Shah DK et al (2011) Echocardiographic predictors of adverse outcomes after continuous left ventricular assist device implantation. JACC Cardiovasc Imaging 4(3):211–222

Article  PubMed  Google Scholar 

Kukucka M, Stepanenko A, Potapov E et al (2011) Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices. J Heart Lung Transplant 30(1):64–69

Article  PubMed  Google Scholar 

Wan K, Sun J, Han Y et al (2018) Right ventricular involvement evaluated by cardiac magnetic resonance imaging predicts mortality in patients with light chain amyloidosis. Heart Vessels 33(2):170–179

Article  PubMed  Google Scholar 

Liu D, Hu K, Herrmann S et al (2017) Value of tissue Doppler-derived Tei index and two-dimensional speckle tracking imaging derived longitudinal strain on predicting outcome of patients with light-chain cardiac amyloidosis. Int J Cardiovasc Imaging 33(6):837–845

Article  PubMed  PubMed Central  Google Scholar 

Ghio S, Perlini S, Palladini G et al (2007) Importance of the echocardiographic evaluation of right ventricular function in patients with AL amyloidosis. Eur J Heart Fail 9(8):808–813

Article  PubMed  Google Scholar 

Bellavia D, Pellikka PA, Al-Zahrani GB et al (2010) Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study. J Am Soc Echocardiogr 23(6):643–652

Article  PubMed  PubMed Central  Google Scholar 

Fine NM, White JA, Jimenez-Zepeda V et al (2020) Determinants and prognostic significance of serial right heart function changes in patients with cardiac amyloidosis. Can J Cardiol 36(3):432–440

Article  PubMed  Google Scholar 

Wan K, Lin J, Guo X et al (2020) Prognostic value of right ventricular dysfunction in patients with AL amyloidosis: comparison of different techniques by cardiac magnetic resonance. J Magn Reson Imaging 52(5):1441–1448

Article  PubMed  Google Scholar 

Maleszewski JJ (2015) Cardiac amyloidosis: pathology, nomenclature, and typing. Cardiovasc Pathol 24(6):343–350

Article  CAS  PubMed  Google Scholar 

Brenner DA, Jain M, Pimentel DR, Wang B, Connors LH, Skinner M et al (2004) Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress. Circ Res 94(8):1008–1010

Article  CAS  PubMed  Google Scholar 

Binder C, Duca F, Stelzer PD et al (2019) Mechanisms of heart failure in transthyretin vs. light chain amyloidosis. Eur Heart J Cardiovasc Imaging 20(5):512–524

Article  PubMed  Google Scholar 

Cappelli F, Porciani MC, Bergesio F et al (2012) Right ventricular function in AL amyloidosis: characteristics and prognostic implication. Eur Heart J Cardiovasc Imaging 13:416–422

Article  PubMed  Google Scholar 

Dungu J, Whelan CJ, Gibbs SD et al (2012) Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis. J Cardiovasc Magn Reson 14:O87

Article  PubMed Central  Google Scholar 

Phelan D, Collier P, Thavendiranathan P et al (2012) Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98:1442–1448

Article  PubMed  Google Scholar 

Moñivas Palomero V, Durante-Lopez A, Sanabria MT et al (2019) Role of right ventricular strain measured by two-dimensional echocardiography in the diagnosis of cardiac amyloidosis. J Am Soc Echocardiogr 32(7):845-853.e1

Article  PubMed  Google Scholar 

Mehta P, Chapel DB, Goyal N et al (2019) A histopathologic schema to quantify the burden of cardiac amyloidosis: relationship with survival and echocardiographic parameters. Echocardiography 36(2):285–291

Article  PubMed  Google Scholar 

Kim D, Choi JO, Kim K, Kim SJ, Kim JS, Jeon ES (2021) Clinical and prognostic implications of capillary density in patients with cardiac light chain amyloidosis. ESC Heart Fail 8(6):5594–5599

Article  PubMed  PubMed Central  Google Scholar 

Nicol M, Siguret V, Vergaro G et al (2022) Thromboembolism and bleeding in systemic amyloidosis: a review. ESC Heart Fail 9(1):11–20. 

Article  PubMed  Google Scholar 

Tanaka Y, Hosotani K, Fukushima M (2020) A case of amyloid light-chain amyloidosis presenting with submucosal hematoma and bleeding in the upper gastrointestinal tract. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 18:e158–e159

Google Scholar 

Sundaram S, Rathod R (2019) Gastric amyloidosis causing nonvariceal upper gastrointestinal bleeding. ACG Case Rep J 6:3–4

Article  PubMed  Google Scholar 

Kumar S, Dispenzieri A, Lacy MQ, Litzow MR, Gertz MA (2001) High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosis. Bone Marrow Transplant 28:381–385

Article  CAS  PubMed  Google Scholar 

Tabit CE, Chen P, Kim GH, Fedson SE, Sayer G, Coplan MJ, Jeevanandam V, Uriel N, Liao JK (2016) Elevated Angiopoietin-2 level in patients with continuous-flow left ventricular assist devices leads to altered angiogenesis and is associated with higher nonsurgical bleeding. Circulation 134:141–152

Article  CAS  PubMed  PubMed Central 

留言 (0)

沒有登入
gif